117 related articles for article (PubMed ID: 6601649)
1. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Haemophilus ducreyi.
Hammond GW; Lian CJ; Wilt JC; Ronald AR
Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
Sturm AW
J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
[TBL] [Abstract][Full Text] [Related]
5. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
Aldridge KE; Cammarata C; Martin DH
Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
[TBL] [Abstract][Full Text] [Related]
7. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
Feltham S; Ronald AR; Albritton WL
J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
[No Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Haemophilus ducreyi. A study.
Sng EH; Lim AL; Rajan VS; Goh AJ
Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
Abeck D; Johnson AP; Dangor Y; Ballard RC
J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of antibacterial agents on Haemophilus influenzae isolates.
Chugh TD; Neil L; Mahboob AG; Araj GF
Trop Geogr Med; 1986 Dec; 38(4):404-7. PubMed ID: 3492795
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products.
Slootmans L; Vanden Berghe DA; Van Dyck E; Piot P
Antimicrob Agents Chemother; 1983 Oct; 24(4):564-7. PubMed ID: 6606394
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
18. [Serotype distribution and drug resistance of
Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
[No Abstract] [Full Text] [Related]
19. Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.
Sanson-le Pors MJ; Casin IM; Collatz E
Antimicrob Agents Chemother; 1985 Aug; 28(2):315-9. PubMed ID: 3010843
[TBL] [Abstract][Full Text] [Related]
20. Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M
Antimicrob Agents Chemother; 1979 Dec; 16(6):757-60. PubMed ID: 316989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]